当前位置: 首页 >> 检索结果
共有 16822 条符合本次的查询结果, 用时 5.1697087 秒

2021. A programme for greater health equity for the next UK Government.

作者: Michael Marmot.;Jessica Allen.
来源: Lancet. 2024年403卷10445期2675-2677页

2022. Ulcers, stress, and the discovery of Helicobacter pylori.

作者: Christopher Crenner.
来源: Lancet. 2024年403卷10444期2586-2587页

2023. Mental health in emergencies requires "a major rethink".

作者: John Zarocostas.
来源: Lancet. 2024年403卷10444期2582页

2024. Israel border closure denying health care to Gazans.

作者: Saleyha Ahsan.
来源: Lancet. 2024年403卷10444期2581页

2025. African vaccine manufacturing scheme to boost production.

作者: Udani Samarasekera.
来源: Lancet. 2024年403卷10444期2579-2580页

2026. Persistent physical symptoms: definition, genesis, and management.

作者: Bernd Löwe.;Anne Toussaint.;Judith G M Rosmalen.;Wei-Lieh Huang.;Christopher Burton.;Angelika Weigel.;James L Levenson.;Peter Henningsen.
来源: Lancet. 2024年403卷10444期2649-2662页
Persistent physical symptoms (synonymous with persistent somatic symptoms) is an umbrella term for distressing somatic complaints that last several months or more, regardless of their cause. These symptoms are associated with substantial disability and represent a major burden for patients, health-care professionals, and society. Persistent physical symptoms can follow infections, injuries, medical diseases, stressful life events, or arise de novo. As symptoms persist, their link to clearly identifiable pathophysiology often weakens, making diagnosis and treatment challenging. Multiple biological and psychosocial risk factors and mechanisms contribute to the persistence of somatic symptoms, including persistent inflammation; epigenetic profiles; immune, metabolic and microbiome dysregulation; early adverse life experiences; depression; illness-related anxiety; dysfunctional symptom expectations; symptom focusing; symptom learning; and avoidance behaviours, with many factors being common across symptoms and diagnoses. Basic care consists of addressing underlying pathophysiology and using person-centred communication techniques with validation, appropriate reassurance, and biopsychosocial explanation. If basic care is insufficient, targeted psychological and pharmacological interventions can be beneficial. A better understanding of the multifactorial persistence of somatic symptoms should lead to more specific, personalised, and mechanism-based treatment, and a reduction in the stigma patients commonly face.

2027. Time-lagged amelioration of vascular endothelial function in malignant hypertension: different organs improved at different rates.

作者: Shin-Ichiro Hayashi.;Yuhei Kawano.;Ryuichi Morishita.;Kengo F Kusano.
来源: Lancet. 2024年403卷10444期2630-2631页

2028. Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trial.

作者: Christopher Burton.;Cara Mooney.;Laura Sutton.;David White.;Jeremy Dawson.;Aileen R Neilson.;Gillian Rowlands.;Steve Thomas.;Michelle Horspool.;Kate Fryer.;Monica Greco.;Tom Sanders.;Ruth E Thomas.;Cindy Cooper.;Emily Turton.;Waquas Waheed.;Jonathan Woodward.;Ellen Mallender.;Vincent Deary.
来源: Lancet. 2024年403卷10444期2619-2629页
People with multiple and persistent physical symptoms have impaired quality of life and poor experiences of health care. We aimed to evaluate the effectiveness of a community-based symptom-clinic intervention in people with multiple and persistent physical symptoms, hypothesising that this symptoms clinic plus usual care would be superior to usual care only.

2031. Challenges in pig-to-human kidney xenotransplantation.

作者: Yu-An Liu.;Chih-Yu Yang.;Der-Cherng Tarng.
来源: Lancet. 2024年403卷10444期2595页

2032. Challenges in pig-to-human kidney xenotransplantation - Authors' reply.

作者: Alexandre Loupy.;Adam Griesemer.;Robert A Montgomery.
来源: Lancet. 2024年403卷10444期2595-2596页

2033. Challenges in pig-to-human kidney xenotransplantation.

作者: Liming Cheng.;Kai Liu.
来源: Lancet. 2024年403卷10444期2595页

2034. Possible causes of graft dysfunction in cardiac xenotransplantation - Authors' reply.

作者: Muhammad M Mohiuddin.;Andy Tully.;Avneesh K Singh.;Javier Galindo.;Bartley P Griffith.
来源: Lancet. 2024年403卷10444期2594-2595页

2035. Possible causes of graft dysfunction in cardiac xenotransplantation.

作者: Hui-Sheng Ai.;Yangyang Lei.;Kaixun Hu.
来源: Lancet. 2024年403卷10444期2593-2594页

2036. Tobacco industry conflicts of interest cannot go undeclared in scientific publishing - Authors' reply.

作者: Derek Yach.
来源: Lancet. 2024年403卷10444期2593页

2037. Improving future UK pandemic management structure.

作者: Ian Kunkler.
来源: Lancet. 2024年403卷10444期2592页

2038. Tobacco industry conflicts of interest cannot go undeclared in scientific publishing.

作者: Tess Legg.;Anna B Gilmore.
来源: Lancet. 2024年403卷10444期2592-2593页

2039. Dual-targeted disease-modifying therapies for osteoarthritis.

作者: Li Zheng.;Zhenhui Lu.;Guojie Xu.;Xing Niu.;Jinmin Zhao.
来源: Lancet. 2024年403卷10444期2591页

2040. Genericisation in cost-effectiveness analysis of cystic fibrosis medicines.

作者: Alice Beattie.;Alex Moore.;Sreeram V Ramagopalan.
来源: Lancet. 2024年403卷10444期2591-2592页
共有 16822 条符合本次的查询结果, 用时 5.1697087 秒